Latest News and Press Releases
Want to stay updated on the latest news?
-
ROUYN-NORANDA, Québec, 12 juin 2018 (GLOBE NEWSWIRE) -- ENTREPRISES MINIÈRES GLOBEX INC. (TSX:GMX) (FRANCFORT:G1MN) (STUTTGART:G1MN) (BERLIN:G1MN) (MUNICH:G1MN) (XETRA:G1MN) (OTCQX:GLBXF) est...
-
ROUYN-NORANDA, Quebec, June 12, 2018 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (TSX:GMX) (FRANKFURT:G1MN) (STUTTGART:G1MN) (BERLIN:G1MN) (MUNICH:G1MN) (XETRA:G1MN) (OTCQX:GLBXF) is pleased...
-
ROUYN-NORANDA, Québec, June 07, 2018 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (TSX:GMX) (FRANKFURT:G1MN) (STUTTGART:G1MN) (BERLIN:G1MN) (MUNICH:G1MN) (XETRA:G1MN) (OTCQX:GLBXF) is...
-
ROUYN-NORANDA, Quebec, June 06, 2018 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (TSX:GMX) (FRANKFURT:G1MN) (STUTTGART:G1MN) (BERLIN:G1MN) (MUNICH:G1MN) (XETRA:G1MN) (OTCQX:GLBXF) reports...
-
ROUYN-NORANDA, Québec, June 05, 2018 (GLOBE NEWSWIRE) -- Globex Mining Enterprises Inc. (TSX:GMX) (FRANKFURT:G1MN) (STUTTGART:G1MN) (BERLIN:G1MN) (MUNICH:G1MN) (XETRA:G1MN) (OTCQX:GLBXF) is...
-
Daten unterstützen Erweiterung der klinischen Evaluierung auf die Phase 2a. Basel, 5. Juni 2018 - Basilea Pharmaceutica AG (SIX: BSLN) berichtete heute über die Präsentation von Phase-1-Daten...
-
Data support expansion into phase 2a Basel, Switzerland, June 05, 2018 - Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that data from the phase 1 dose-escalation parts of two phase 1/2a...
-
ROUYN-NORANDA, Québec, May 31, 2018 (GLOBE NEWSWIRE) -- GLOBEX MINING ENTERPRISES INC. (TSX:GMX) (FRANKFURT:G1MN) (STUTTGART:G1MN) (BERLIN:G1MN) (MUNICH:G1MN) (XETRA:G1MN) (OTCQX:GLBXF) is...
-
TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- Captor Capital Corp. (“Captor” or the “Company”) (CSE:CPTR) (FRANKFURT:NMV) announced today that the closing of the previously announced acquisition of all...
-
TORONTO, May 30, 2018 (GLOBE NEWSWIRE) -- On May 28, 2018, MedMen Enterprises Inc. (formerly Ladera Ventures Corp.) (the “Issuer”), located at 10115 Jefferson Blvd, Culver City, CA 90232, and MM...